Specialty PACS Market by Type, Deployment Model, End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

The global specialty PACS market was valued at $2,682.88 million in 2020, and is projected to reach $4,485.96 million by 2030, registering a CAGR of 5.5% from 2021 to 2030.

PACS (picture archiving and communication system) is a medical imaging technology used primarily in healthcare organizations to securely store and digitally transmit electronic images and clinically-relevant reports. The use of PACS eliminates the need to manually file, store, retrieve, and send sensitive information, films, and reports. In addition, medical documentation and images can be securely housed in off-site servers and safely accessed essentially from anywhere in the world using PACS software, workstations, and mobile devices. Medical imaging storage technologies such as PACS are increasingly important as the volume of digital medical images grow throughout the healthcare industry and data analytics of those images become more prevalent. PACS has four major parts, namely, hardware imaging machines; a secure network for the distribution and exchange of patient images; a workstation or mobile device for viewing, processing, and interpreting images; and electronic archives for storing and retrieving images and related documentation and reports. PACS has various uses that include replacement for need of hard-copy films and management of physical archives. It allows remote access, enabling clinicians in different physical locations to review same data simultaneously.

Increase in geriatric population and growing medical imaging volumes are the key factors that fuel growth of the specialty PACS market. Moreover, rise in prevalence of chronic diseases, increase in investments in medical imaging, rise in use of imaging equipment, increase in adoption of medical imaging health care IT solutions, rise in advancements in specialty PACS, growth in government initiatives to propel adoption of healthcare IT solution, and rise in awareness regarding early disease diagnosis are other factors that contribute toward growth of the market. However, unawareness among people regarding the technology, increase in cost of treatment, slow development in specialty PACS, and less government initiatives are expected to hinder growth of the market. Furthermore, rise in ambulatory centers, increase in advancements in R&D, reduced cost of product and treatment, rise in hospital facilities, and advancements in imaging solution provides lucrative opportunities for the market growth.

The specialty PACS market is segmented into type, deployment model, end user, and region. On the basis of type, the market is categorized into radiology PACS, orthopedics PACS, oncology PACS, pathology PACS, ophthalmology PACS, women’s health PACS, and others. By deployment model, it is categorized into on-premises specialty PACS and cloud-based specialty PACS. On the basis of end user, it is segregated into hospitals & clinics, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the specialty PACS market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves

KEY MARKET SEGMENTS

By TYPE

Radiology PACS
Orthopedics PACS
Oncology PACS
Pathology PACS
Ophthalmology PACS
Women’s health PACS
Other

By DEPLOYMENT MODEL

On-premises Specialty PACS
Cloud-based Specialty PAC

By END USER

Hospitals & Clinics
Ambulatory Surgical Centers
Other

By REGION

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
Australia
India
South Korea
Rest of Asia Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

KEY MARKET PLAYERS

Canon Inc. (Canon Medical System Corporation)
INC Escalon Medical Corp.
EyePACS, LLC
IBM Corporation
INFINITT Healthcare Co. Ltd.
Koninklijke Philips N.V.
McKesson Corporation
Novarad
Onex Corporation (Carestream Health)
Siemens AG

Please note:

Online Access price format is valid for 60 days access. Printing is not enabled.
PDF Single and Enterprise price formats enable printing.

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in investments in medical imaging
3.5.1.2. Rise in use of imaging equipment
3.5.1.3. Surge in geriatric population
3.5.2. Restraint
3.5.2.1. Low awareness regarding the technology
3.5.2.2. Increase in cost of treatment
3.5.3. Opportunity
3.5.3.1. Advancements in imaging solution
3.5.4. Impact analysis
3.6. COVID-19 Impact Analysis on Specialty PACS Market

CHAPTER 4: SPECIALTY PACS MARKET, BY PRODUCT

4.1. Overview
4.1.1. Market size and forecast
4.2. Radiology PACS
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Orthopedics PACS
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Oncology PACS
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Pathology PACS
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Ophthalmology PACS
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Women’s health PACS
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
4.8. Others
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country

CHAPTER 5: SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL

5.1. Overview
5.1.1. Market size and forecast
5.2. On-Premises Specialty PACS
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Cloud-based Specialty PACS
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

CHAPTER 6: SPECIALTY PACS MARKET, BY END USER

6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & clinics
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Ambulatory Surgical Centers
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

CHAPTER 7: SPECIALTY PACS MARKET, BY REGION

7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America market size & forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Specialty PACS market, by type
7.2.2.1.2. U.S. Specialty PACS market, By Deployment model
7.2.2.1.3. U.S. Specialty PACS market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada Specialty PACS market, by type
7.2.2.2.2. Canada Specialty PACS market, By Deployment model
7.2.2.2.3. Canada Specialty PACS market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico Specialty PACS market, by type
7.2.2.3.2. Mexico Specialty PACS market, By Deployment model
7.2.2.3.3. Mexico Specialty PACS market, by end user
7.2.3. North America market size and forecast, by type
7.2.4. North America market size and forecast, By Deployment model
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany Specialty PACS market, by type
7.3.2.1.2. Germany Specialty PACS market, By Deployment model
7.3.2.1.3. Germany Specialty PACS market, by end user
7.3.2.2. France
7.3.2.2.1. France Specialty PACS market, by type
7.3.2.2.2. France Specialty PACS market, By Deployment model
7.3.2.2.3. France Specialty PACS market, by End User
7.3.2.3. UK
7.3.2.3.1. UK Specialty PACS market, by type
7.3.2.3.2. UK Specialty PACS market, By Deployment model
7.3.2.3.3. UK Specialty PACS market, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy Specialty PACS market, by type
7.3.2.4.2. Italy Specialty PACS market, By Deployment model
7.3.2.4.3. Italy Specialty PACS market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain Specialty PACS market, by type
7.3.2.5.2. Spain Specialty PACS market, By Deployment model
7.3.2.5.3. Spain Specialty PACS market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe Specialty PACS market, by type
7.3.2.6.2. Rest of Europe Specialty PACS market, By Deployment model
7.3.2.6.3. Rest of Europe Specialty PACS market, by end user
7.3.3. Europe market size and forecast, by type
7.3.4. Europe market size and forecast, By deployment model
7.3.5. Europe market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan Specialty PACS market, by type
7.4.2.1.2. Japan Specialty PACS market, By Deployment model
7.4.2.1.3. Japan Specialty PACS market, by end user
7.4.2.2. China
7.4.2.2.1. China Specialty PACS market, by type
7.4.2.2.2. China Specialty PACS market, By Deployment model
7.4.2.2.3. China Specialty PACS market, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia Specialty PACS market, by type
7.4.2.3.2. Australia Specialty PACS market, By Deployment model
7.4.2.3.3. Australia Specialty PACS market, by end user
7.4.2.3.4. India Specialty PACS market, by type
7.4.2.3.5. India Specialty PACS market, By Deployment model
7.4.2.3.6. India Specialty PACS market, by end user
7.4.2.4. South Korea
7.4.2.4.1. South Korea Specialty PACS market, by type
7.4.2.4.2. South Korea Specialty PACS market, By Deployment model
7.4.2.4.3. South Korea Specialty PACS market, by end user
7.4.2.5. Rest of Asia-Pacific
7.4.2.5.1. Rest of Asia-Pacific Specialty PACS market, by type
7.4.2.5.2. Rest of Asia-Pacific Specialty PACS market, By Deployment model
7.4.2.5.3. Rest of Asia-Pacific Specialty PACS market, by end user
7.4.3. Asia-Pacific market size and forecast, by type
7.4.4. Asia-Pacific market size and forecast, By Deployment model
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil Specialty PACS market, by type
7.5.2.1.2. Brazil Specialty PACS market, By Deployment model
7.5.2.1.3. Brazil Specialty PACS market, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia Specialty PACS market, by type
7.5.2.2.2. Saudi Arabia Specialty PACS market, By Deployment model
7.5.2.2.3. Saudi Arabia Specialty PACS market, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa Specialty PACS market, by type
7.5.2.3.2. South Africa Specialty PACS market, By Deployment model
7.5.2.3.3. South Africa Specialty PACS market, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA Specialty PACS market, by type
7.5.2.4.2. Rest of LAMEA Specialty PACS market, By Deployment model
7.5.2.4.3. Rest of LAMEA Specialty PACS market, by end user
7.5.3. LAMEA market size and forecast, by type
7.5.4. LAMEA market size and forecast, By Deployment model
7.5.5. LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Canon Inc. (Canon Medical System Corporation)
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. Escalon Medical Corp.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. EyePACS, LLC
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.4. IBM Corporation
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. INFINITT Healthcare Co. Ltd.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Key strategic moves and developments
8.6. Koninklijke Philips N.V.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. McKesson Corporation
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. Novarad
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.9. Onex Corporation (Carestream Health)
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. Siemens AG
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

List of Tables

TABLE 01. SPECIALTY PACS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 02. SPECIALTY PACS MARKET FOR RADIOLOGY PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 03. SPECIALTY PACS MARKET FOR ORTHOPEDICS PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 04. SPECIALTY PACS MARKET FOR ONCOLOGY PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 05. SPECIALTY PACS MARKET FOR PATHOLOGY PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 06. SPECIALTY PACS MARKET FOR OPHTHALMOLOGY PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 07. SPECIALTY PACS MARKET FOR WOMEN HEALTH PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 08. SPECIALTY PACS MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 09. SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 10. SPECIALTY PACS MARKET FOR ON-PREMISES SPECIALTY PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 11. SPECIALTY PACS FOR CLOUD-BASED SPECIALTY PACS, BY REGION, 2020–2030 ($MILLION)
TABLE 12. SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 13. SPECIALTY PACS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2030 ($MILLION)
TABLE 14. SPECIALTY PACS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 15. SPECIALTY PACS MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 16. SPECIALTY PACS MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 17. NORTH AMERICA SPECIALTY PACS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 18. U.S. SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 19. U.S. SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 20. U.S. SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 21. CANADA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 22. CANADA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 23. CANADA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 24. MEXICO SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 25. MEXICO SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 26. MEXICO SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 27. NORTH AMERICA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 28. NORTH AMERICA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 29. NORTH AMERICA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 30. EUROPE SPECIALTY PACS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 31. GERMANY SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 32. GERMANY SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 33. GERMANY SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 34. FRANCE SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 35. FRANCE SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 36. FRANCE SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 37. UK SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 38. UK SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 39. UK SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 40. ITALY SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 41. ITALY SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 42. ITALY SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 43. SPAIN SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 44. SPAIN SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 45. SPAIN SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 46. REST OF EUROPE SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 47. REST OF EUROPE SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 48. REST OF EUROPE SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 49. EUROPE SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 50. EUROPE SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 51. EUROPE SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 52. ASIA-PACIFIC SPECIALTY PACS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 53. JAPAN SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 54. JAPAN SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 55. JAPAN SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 56. CHINA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 57. CHINA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 58. CHINA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 59. AUSTRALIA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 60. AUSTRALIA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 61. AUSTRALIA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 62. INDIA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 63. INDIA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 64. INDIA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 65. SOUTH KOREA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 66. SOUTH KOREA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 67. SOUTH KOREA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 71. ASIA-PACIFIC SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 72. ASIA-PACIFIC SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 73. ASIA-PACIFIC SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 74. LAMEA SPECIALTY PACS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 75. BRAZIL SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 76. BRAZIL SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 77. BRAZIL SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 78. SAUDI ARABIA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 79. SAUDI ARABIA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 80. SAUDI ARABIA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 81. SOUTH AFRICA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 82. SOUTH AFRICA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 83. SOUTH AFRICA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 84. REST OF LAMEA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 85. REST OF LAMEA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 86. REST OF LAMEA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 87. LAMEA SPECIALTY PACS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 88. LAMEA SPECIALTY PACS MARKET, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)
TABLE 89. LAMEA SPECIALTY PACS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 90. CANON: COMPANY SNAPSHOT
TABLE 91. CANON: OPERATING SEGMENTS
TABLE 92. CANON: PRODUCT PORTFOLIO
TABLE 93. ESCALON: COMPANY SNAPSHOT
TABLE 94. ESCALON: OERATING SEGMENT
TABLE 95. ESCALON: PRODUCT PORTFOLIO
TABLE 96. EYEPACS: COMPANY SNAPSHOT
TABLE 97. EYEPACS: OPERATING SEGMENTS
TABLE 98. EYEPACS: PRODUCT PORTFOLIO
TABLE 99. IBM: COMPANY SNAPSHOT
TABLE 100. IBM: OPERATING SEGMENTS
TABLE 101. IBM: PRODUCT PORTFOLIO
TABLE 102. INFINITT: COMPANY SNAPSHOT
TABLE 103. INFINITT: OERATING SEGMENT
TABLE 104. INFINITT.: PRODUCT PORTFOLIO
TABLE 105. INFINITT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. PHILLIPS: COMPANY SNAPSHOT
TABLE 107. PHILLIPS: OPERATING SEGMENTS
TABLE 108. PHILLIPS: PRODUCT PORTFOLIO
TABLE 109. MCKESSON: COMPANY SNAPSHOT
TABLE 110. MCKESSON: OERATING SEGMENT
TABLE 111. MCKESSON: PRODUCT PORTFOLIO
TABLE 112. NOVARAD: COMPANY SNAPSHOT
TABLE 113. NOVARAD: OPERATING SEGMENTS
TABLE 114. NOVARAD: PRODUCT PORTFOLIO
TABLE 115. ONEX: COMPANY SNAPSHOT
TABLE 116. ONEX: OPERATING SEGMENTS
TABLE 117. ONEX: PRODUCT PORTFOLIO
TABLE 118. SIEMENS: COMPANY SNAPSHOT
TABLE 119. SIEMENS: OPERATING SEGMENTS
TABLE 120. SIEMENS: PRODUCT PORTFOLIO
TABLE 121. SIEMENS: KEY STRATEGIC MOVES AND DEVELOPMENTS

List of Figures

FIGURE 01. SPECIALTY PACS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 04. MODERATE BARGAINING POWER OF BUYERS
FIGURE 05. MODERATE THREAT OF SUBSTITUTES
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. HIGH INTENSITY OF RIVALRY
FIGURE 08. TOP PLAYER POSITIONING, 2020
FIGURE 09. IMPACT ANALYSIS
FIGURE 10. COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR RADIOLOGY PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 11. COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR ORTHOPEDICS PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 12. COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR ONCOLOGY PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 13. COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR PATHOLOGY PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR OPHTHALMOLOGY PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR WOMEN HEALTH PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR OTHERS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR ON-PREMISES SPECIALTY PACS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF SPECIALTY PACS FOR CLOUD-BASED SPECIALTY PACS SEGMENT, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF SPECIALTY PACS MARKET FOR OTHERS, BY COUNTRY, 2020–2030 ($MILLION)
FIGURE 22. CANON: NET SALES, 2018–2020 ($MILLION)
FIGURE 23. CANON: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 24. CANON: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 25. ESCALON: NET SALES, 2018–2020 ($MILLION)
FIGURE 26. ESCALON: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 27. IBM: NET SALES, 2018–2020 ($MILLION)
FIGURE 28. IBM: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 29. IBM: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 30. PHILLIPS: NET SALES, 2018–2020 ($MILLION)
FIGURE 31. PHILLIPS: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 32. PHILLIPS: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 33. MCKESSON: NET SALES, 2019–2021 ($MILLION)
FIGURE 34. MCKESSON: REVENU.S.ARE BY SEGMENT, 2021 (%)
FIGURE 35. ONEX: NET SALES, 2018–2020 ($MILLION)
FIGURE 36. ONEX: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 37. SIEMENS: NET SALES, 2019–2021 ($MILLION)
FIGURE 38. SIEMENS: REVENU.S.ARE BY SEGMENT, 2021 (%)
FIGURE 39. SIEMENS: REVENU.S.ARE BY SEGMENT, 2021 (%)

Companies Mentioned

Canon Inc. (Canon Medical System Corporation)
Escalon Medical Corp.
EyePACS LLC
IBM Corporation
INFINITT Healthcare Co. Ltd.
Koninklijke PhilipsN.V.
McKesson Corporation
Novarad
Onex Corporation
Siemens AG

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic news articles and other related releases for market evaluation
Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

LOADING...

Table Information

Report Attribute	Details
No. of Pages	224
Published	January 2022
Forecast Period	2020 - 2030
Estimated Market Value ( USD ) in 2020	$ 2682.88 million
Forecasted Market Value ( USD ) by 2030	$ 4485.96 million
Compound Annual Growth Rate	5.3%
Regions Covered	Global
No. of Companies Mentioned	10

License	Format	Properties	Price
SINGLE USER LICENSE Online Access		This is a single user license, allowing one user access to the product.	€3659EUR$3,712USD£3,026GBP
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4834EUR$4,904USD£3,997GBP €5687EUR$5,769USD£4,702GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8409EUR$8,530USD£6,953GBP €10511EUR$10,663USD£8,691GBP

KEY BENEFITS FOR STAKEHOLDERS

KEY MARKET SEGMENTS

By TYPE

By DEPLOYMENT MODEL

By END USER

By REGION

KEY MARKET PLAYERS

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Specialty PACS Market by Component, Type, Deployment, End-User - Global Forecast 2025-2030

Specialty PACS Global Market Report 2024

Specialty Picture Archiving and Communication Systems (PACS) - Global Strategic Business Report

Specialty PACS - Market Insights, Competitive Landscape, and Market Forecast - 2030

Specialty PACS Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)